B. N. Prashanth Kumar

1.8k citations

25 papers · 1.4k · h-index 20

Impact in

Toxicology top 2%
- Bioactive Compounds and Antitumor Agents
Complementary and alternative medicine top 2%
- Nigella sativa pharmacological applications

Papers in

Biomaterials 9
- Nanoparticle-Based Drug Delivery 9
Molecular Biology 8
- Cell death mechanisms and regulation 2

Co-authors: Mahitosh Mandal (22 shared papers)Shashi Rajput (14 shared papers)Nagaprasad Puvvada (8 shared papers)Amita Pathak (9 shared papers)Suraj Konar (7 shared papers)Paul B. Fisher (8 shared papers)Kaushik Dey (6 shared papers)Himani Kalita (3 shared papers)
Journals: RSC Advances (2 papers)Molecular Pharmaceutics (2 papers)Journal of Materials Chemistry B (2 papers)Scientific Reports (2 papers)Cancer Letters (1 paper)
Partner nations: India United States Canada

In The Last Decade

B. N. Prashanth Kumar

25 papers receiving 1.4k citations

Peers

Countries citing papers authored by B. N. Prashanth Kumar

Since Specialization

Citations

This map shows the geographic impact of B. N. Prashanth Kumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. N. Prashanth Kumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. N. Prashanth Kumar more than expected).

Fields of papers citing papers by B. N. Prashanth Kumar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. N. Prashanth Kumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. N. Prashanth Kumar. The network helps show where B. N. Prashanth Kumar may publish in the future.

Co-authors

The 25 scholars most cited alongside B. N. Prashanth Kumar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with B. N. Prashanth Kumar Line = papers co-authored together B. N. Prashanth Kumar links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	The potential of celecoxib-loaded hydroxyapatite-chitosan nanocomposite for the treatment of colon cancer Biomaterials ·P. Venkatesan, Nagaprasad Puvvada, Rupesh Dash, B. N. Prashanth Kumar, Devanand Sarkar, Belal Azab, Amita Pathak, Subhas C. Kundu, Paul B. Fisher, Mahitosh Mandal	2011	218
2	Synthesis of biocompatible multicolor luminescent carbon dots for bioimaging applications Science and Technology of Advanced Materials ·Nagaprasad Puvvada, B. N. Prashanth Kumar, Suraj Konar, Himani Kalita, Mahitosh Mandal, Amita Pathak	2012	161
3	Molecular targeting of Akt by thymoquinone promotes G1 arrest through translation inhibition of cyclin D1 and induces apoptosis in breast cancer cells Life Sciences ·Shashi Rajput, B. N. Prashanth Kumar, Kaushik Dey, Ipsita Pal, Aditya Parekh, Mahitosh Mandal	2013	109
4	Targeted Apoptotic Effects of Thymoquinone and Tamoxifen on XIAP Mediated Akt Regulation in Breast Cancer PLoS ONE ·Shashi Rajput, B. N. Prashanth Kumar, Siddik Sarkar, Subhasis Das, Belal Azab, Prasanna K. Santhekadur, Swadesh K. Das, Luni Emdad, Devanand Sarkar, Paul B. Fisher, Mahitosh Mandal	2013	105
5	Marine lipopeptide Iturin A inhibits Akt mediated GSK3β and FoxO3a signaling and triggers apoptosis in breast cancer Scientific Reports ·Goutam Dey, Rashmi Bharti, Gunaseelan Dhanarajan, Subhasis Das, Kaushik Dey, B. N. Prashanth Kumar, Ramkrishna Sen, Mahitosh Mandal	2015	99
6	N-doped carbon dot as fluorescent probe for detection of cysteamine and multicolor cell imaging Sensors and Actuators B Chemical ·Suraj Konar, B. N. Prashanth Kumar, Madhusudan Kr. Mahto, Dipanjan Samanta, Md Abdus Salam Shaik, Manisha Shaw, Mahitosh Mandal, Amita Pathak	2019	89
7	Photoresponsive Coumarin-Tethered Multifunctional Magnetic Nanoparticles for Release of Anticancer Drug ACS Applied Materials & Interfaces ·(unknown), Nagaprasad Puvvada, B. N. Prashanth Kumar, Shashi Rajput, Amita Pathak, Mahitosh Mandal, N. D. Pradeep Singh	2013	79
8	Novel ZnO hollow-nanocarriers containing paclitaxel targeting folate-receptors in a malignant pH-microenvironment for effective monitoring and promoting breast tumor regression Scientific Reports ·Nagaprasad Puvvada, Shashi Rajput, B. N. Prashanth Kumar, Siddik Sarkar, Suraj Konar, Keith R. Brunt, Raj R. Rao, Abhijit Mazumdar, Swadesh K. Das, Ranadhir Basu, Paul B. Fisher, Mahitosh Mandal, Amita Pathak	2015	74
9	Somatostatin receptor targeted liposomes with Diacerein inhibit IL-6 for breast cancer therapy Cancer Letters ·Rashmi Bharti, Goutam Dey, Indranil Banerjee, Kaushik Dey, Sheetal Parida, B. N. Prashanth Kumar, Chandan Kanta Das, Ipsita Pal, M. Mukherjee, Mridula Misra, Anjan K. Pradhan, Luni Emdad, Swadesh K. Das, Paul B. Fisher, Mahitosh Mandal	2016	68
10	Overcoming Akt Induced Therapeutic Resistance in Breast Cancer through siRNA and Thymoquinone Encapsulated Multilamellar Gold Niosomes Molecular Pharmaceutics ·Shashi Rajput, Nagaprasad Puvvada, B. N. Prashanth Kumar, Siddik Sarkar, Suraj Konar, Rashmi Bharti, Goutam Dey, Abhijit Mazumdar, Amita Pathak, Paul B. Fisher, Mahitosh Mandal	2015	63
11	Celecoxib alleviates tamoxifen-instigated angiogenic effects by ROS-dependent VEGF/VEGFR2 autocrine signaling BMC Cancer ·B. N. Prashanth Kumar, Shashi Rajput, Kaushik Dey, Aditya Parekh, Subhasis Das, Abhijit Mazumdar, Mahitosh Mandal	2013	60
12	Thymoquinone Restores Radiation‐Induced TGF‐β Expression and Abrogates EMT in Chemoradiotherapy of Breast Cancer Cells Journal of Cellular Physiology ·Shashi Rajput, B. N. Prashanth Kumar, Payel Banik, Sheetal Parida, Mahitosh Mandal	2014	45
13	Sonochemically synthesized biocompatible zirconium phosphate nanoparticles for pH sensitive drug delivery application Materials Science and Engineering C ·Himani Kalita, B. N. Prashanth Kumar, Suraj Konar, Sangeeta Tantubay, Madhusudan Kr. Mahto, Mahitosh Mandal, Amita Pathak	2015	42
14	Micellear Gold Nanoparticles as Delivery Vehicles for Dual Tyrosine Kinase Inhibitor ZD6474 for Metastatic Breast Cancer Treatment Langmuir ·Siddik Sarkar, Suraj Konar, (unknown), Shashi Rajput, B. N. Prashanth Kumar, Raj R. Rao, Amita Pathak, Paul B. Fisher, Mahitosh Mandal	2017	36
15	A targeted, image-guided and dually locked photoresponsive drug delivery system Journal of Materials Chemistry B ·(unknown), B. N. Prashanth Kumar, Moumita Gangopadhyay, Mahitosh Mandal, N. D. Pradeep Singh	2014	30
16	Targeting of EGFR, VEGFR2, and Akt by Engineered Dual Drug Encapsulated Mesoporous Silica–Gold Nanoclusters Sensitizes Tamoxifen-Resistant Breast Cancer Molecular Pharmaceutics ·B. N. Prashanth Kumar, Nagaprasad Puvvada, Shashi Rajput, Siddik Sarkar, Madhusudan Kr. Mahto, Murali M. Yallapu, (unknown), Luni Emdad, Swadesh K. Das, Rui L. Reis, Subhas C. Kundu, Paul B. Fisher, Mahitosh Mandal	2018	27
17	Exploring the fluorescence switching phenomenon of curcumin encapsulated niosomes: in vitro real time monitoring of curcumin release to cancer cells RSC Advances ·Nagaprasad Puvvada, Shashi Rajput, B. N. Prashanth Kumar, Mahitosh Mandal, Amita Pathak	2013	25
18	Sequential release of drugs from hollow manganese ferrite nanocarriers for breast cancer therapy Journal of Materials Chemistry B ·B. N. Prashanth Kumar, Nagaprasad Puvvada, Shashi Rajput, Siddik Sarkar, Swadesh K. Das, Luni Emdad, Devanand Sarkar, P. Venkatesan, Ipsita Pal, Goutam Dey, Suraj Konar, Keith R. Brunt, Raj R. Rao, Abhijit Mazumdar, Subhas C. Kundu, Amita Pathak, Paul B. Fisher, Mahitosh Mandal	2014	23
19	BI2536 – A PLK inhibitor augments paclitaxel efficacy in suppressing tamoxifen induced senescence and resistance in breast cancer cells Biomedicine & Pharmacotherapy ·B. N. Prashanth Kumar, Shashi Rajput, Rashmi Bharti, Sheetal Parida, Mahitosh Mandal	2015	21
20	Identification of RAB2A and PRDX1 as the potential biomarkers for oral squamous cell carcinoma using mass spectrometry-based comparative proteomic approach Tumor Biology ·Kaushik Dey, Ipsita Pal, Rashmi Bharti, Goutam Dey, B. N. Prashanth Kumar, Shashi Rajput, Aditya Parekh, Sheetal Parida, Priyanka Halder, Indranil Kulavi, Mahitosh Mandal	2015	19

About B. N. Prashanth Kumar

B. N. Prashanth Kumar is a scholar working on Biomaterials, Molecular Biology, Biomedical Engineering, Materials Chemistry and Organic Chemistry, having authored 25 papers that have together received 1.4k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (9 papers), Nanoplatforms for cancer theranostics (7 papers), Nanocluster Synthesis and Applications (3 papers), Nigella sativa pharmacological applications (3 papers), Inflammatory mediators and NSAID effects (2 papers), Cell death mechanisms and regulation (2 papers), Carbon and Quantum Dots Applications (2 papers) and Natural Compounds in Disease Treatment (2 papers). The work is most often cited by research in Toxicology (111 citations), Complementary and alternative medicine (201 citations), Biomaterials (317 citations), Molecular Medicine (65 citations) and Pharmaceutical Science (63 citations). B. N. Prashanth Kumar has collaborated with scholars based in India, United States and Canada. Frequent co-authors include Mahitosh Mandal, Shashi Rajput, Nagaprasad Puvvada, Amita Pathak, Suraj Konar, Paul B. Fisher, Kaushik Dey, Himani Kalita, Devanand Sarkar and Belal Azab. Their work appears in journals such as RSC Advances, Molecular Pharmaceutics, Journal of Materials Chemistry B, Scientific Reports and Cancer Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

B. N. Prashanth Kumar

Impact in

Papers in i

In The Last Decade

B. N. Prashanth Kumar

Peers

Countries citing papers authored by B. N. Prashanth Kumar

Fields of papers citing papers by B. N. Prashanth Kumar

All Works

About B. N. Prashanth Kumar

Explore authors with similar magnitude of impact

Papers in